Vertex Newswire

Comprehensive Real-Time News Feed for Vertex.

Results 1 - 20 of 277 in Vertex

  1. Six local companies with drugs in clinical trials for rare diseasesRead the original story w/Photo

    Thursday Aug 14 | Business Journal

    The longtime presence of companies like Genzyme, Shire and Vertex in the area has helped make Cambridge and the surrounding area a world center for rare disease drug research.

    Comment?

  2. Biotechs lift Wall StreetRead the original story w/Photo

    Wednesday Aug 13 | Iol.co.za

    ... instead. An S&P index of healthcare stocks jumped 1.2 percent during the regular session and led the S&P 500 higher. Vertex Pharmaceuticals shares, the biggest gainer in the S&P 500 healthcare sector, shot up 3.9 percent to $88.75. Amazon shares ...

    Comment?

  3. Stocks rally, led by surging biotechsRead the original story

    Wednesday Aug 13 | UnionLeader.com

    ... instead. During the regular session, an S&P index of healthcare stocks jumped 1.2 percent and led the S&P 500 higher. Vertex Pharmaceuticals shares, the biggest gainer in the S&P 500 healthcare sector, shot up 3.9 percent to $88.75. Nearly two weeks ...

    Comment?

  4. Wall Street rallies, led by biotechs; retailers weakRead the original story

    Wednesday Aug 13 | Buenos Aires Herald

    ... During the regular session, an S&P index of healthcare stocks jumped 1.2 percent and led the S&P 500 higher. Vertex Pharmaceuticals shares, the biggest gainer in the S&P 500 healthcare sector, shot up 3.9 percent to $88.75. About 4.7 billion shares ...

    Comment?

  5. Us Stocks-Wall Street rises, biotech shares lead rallyRead the original story

    Wednesday Aug 13 | Reuters

    ... said the convoy would not be allowed to pass. Health care stocks led gains in the S&P 500, rising 1.2 percent. Vertex Pharmaceuticals shares rose 4 percent to $88.81 after the company received approval in Europe to use its treatment Kayldeco on ...

    Comment?

  6. Wednesday's ETF with Unusual Volume: PBPRead the original story w/Photo

    Wednesday Aug 13 | Forbes.com

    ... shares changing hands so far this session, and Facebook (FB), up about 1.8% on volume of over 19.7 million shares. Vertex Pharmaceuticals (VRTX) is the component faring the best Wednesday, up by about 3.7% on the day, while Macys (M) is lagging ...

    Comment?

  7. Vertex volatility at record lowRead the original story

    Thursday Jul 31 | Theflyonthewall.com

    Vertex receives European approval for KALYDECO in eight gating mutations Vertex Pharmaceuticals announced that the European Commission has approved KALYDECO for people with cystic fibrosis ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator gene.

    Comment?

  8. Vertex Pharmaceuticals (MA) To Stop Selling Once-Upon-A-Time Blockbuster Incivek, Shares SlipRead the original story

    Tuesday Aug 12 | BioSpace

    Vertex Pharmaceuticals has notified health care providers that it will stop selling its first blockbuster drug, Incivek, in about two months.

    Comment?

  9. Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in OctoberRead the original story w/Photo

    Tuesday Aug 12 | Business Journal

    Incivek was the first approved drug for Vertex in 2011, but it was quickly overwhelmed by competition from other hepatitis C treatment, including Gilead's Sovaldi.

    Comment?

  10. S&P 500 Movers: VRTX, KMIRead the original story w/Photo

    Monday Aug 11 | Forbes.com

    ... Year to date, Kinder Morgan registers a 8.4% gain. And the worst performing S&P 500 component thus far on the day is Vertex Pharmaceuticals (VRTX), trading down 1.6%. Vertex Pharmaceuticals is showing a gain of 14.5% looking at the year to date ...

    Comment?

  11. Nasdaq 100 Movers: ILMN, TSLARead the original story w/Photo

    Monday Aug 11 | Forbes.com

    ... umina is showing a gain of 48.3% looking at the year to date performance. Two other components making moves today are Vertex Pharmaceuticals (VRTX), trading down 1.6%, and Priceline Group (PCLN), trading up 3.0% on the day.

    Comment?

  12. Got a Date with the FDA? Conducting Successful MeetingsRead the original story

    Thursday Aug 7 | BioResearch Online

    ... space though her expertise is around the development of drug products. Prior to joining Halloran, Heather worked at Vertex Pharmaceuticals as a Manager of Regulatory Affairs in the Global Clinical Regulatory Strategy group. In this role, she was the ...

    Comment?

  13. Vertex's Price And Prospects Compared To AlexionRead the original story

    Thursday Aug 7 | Seeking Alpha

    In the past, I have written fairly negative assessments on the value of Vertex .

    Comment?

  14. Yes, it costs $300K a year, but new cystic fibrosis drug is a breakthrough, OHSU specialist saysRead the original story w/Photo

    Wednesday Aug 6 | Business Journal

    ... reduced hospitalizations. It changed the environment of the lung to make it more normal." Kalydeco was developed by Vertex Pharmaceuticals and approved by the U.S. Food and Drug Administration in 2012. It is the first drug that targets the ...

    Comment?

  15. FXD, RYH: Big ETF InflowsRead the original story w/Photo

    Tuesday Aug 5 | Forbes.com

    ... , for a 36.1% increase in outstanding units. Among the largest underlying components of RYH, in morning trading today Vertex Pharmaceuticals (VRTX) is up about 0.4%, and Covidien (COV) is lower by about 0.1%.

    Comment?

  16. Perlstein Lab Raises $2 Million For Orphan Drug DiscoveryRead the original story

    Tuesday Aug 5 | BioSpace

    ... studies in genetically matched patient cells. The successful cystic fibrosis drug Kalydeco, which was developed by Vertex Pharmaceuticals with financial contributions from the Cystic Fibrosis Foundation, proves that specific mutations can be ...

    Comment?

  17. Senior Housing Properties Trust (SNH) Q2 2014 Results - Earnings Call TranscriptRead the original story

    Monday Aug 4 | Seeking Alpha

    ... impactful steps was the completion of the $1.1 billion acquisition of the two biotech research buildings leased to Vertex Pharmaceuticals on May 7. Following our successful capital raising activities and consistent with our previous guidance, we ...

    Comment?

  18. Net@Work Expands Sage Market Presence With Acquisition, Vertex DealRead the original story w/Photo

    Monday Aug 4 | CRN

    Solution provider Net @ Work continues to expand its business within the Sage Software arena, recently acquiring another Sage reseller and striking a deal with Vertex to bring that developer's sales tax applications to the Sage market.

    Comment?

  19. Nasdaq 100 Movers: CTRX, VRTXRead the original story w/Photo

    Monday Aug 4 | Forbes.com

    In early trading on Monday, shares of Vertex Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.3%.

    Comment?

  20. Senior Housing Properties Trust Announces 2014 Second Quarter ResultsRead the original story

    Jun 30, 2014 | Business Wire

    ... as we reported same property NOI growth across all property types, we completed the $1.1 billion acquisition of the Vertex Pharmaceuticals headquarters located in the Seaport District of Boston, and we successfully completed a disciplined capital ...

    Comment?